Atopic Dermatitis Clinical Trials

54 studies are recruiting for atopic dermatitis in the United States right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

By city

New York, New York 12 Los Angeles, California 11 Miami, Florida 9 Birmingham, Alabama 8 Dallas, Texas 8 Sacramento, California 8 San Diego, California 8 Indianapolis, Indiana 7 Philadelphia, Pennsylvania 7 San Antonio, Texas 7 Tampa, Florida 7 Troy, Michigan 7 Chicago, Illinois 6 Northridge, California 6 Pittsburgh, Pennsylvania 6 Sugar Land, Texas 6 Bethesda, Maryland 5 Boca Raton, Florida 5 Charleston, South Carolina 5 Fountain Valley, California 5 Phoenix, Arizona 5 Portland, Oregon 5 St. Petersburg, Florida 5 Ann Arbor, Michigan 4 Coral Gables, Florida 4 Jacksonville, Florida 4 Las Vegas, Nevada 4 Morgantown, West Virginia 4 North Miami Beach, Florida 4 Omaha, Nebraska 4 Portsmouth, New Hampshire 4 Rockville, Maryland 4 Santa Monica, California 4 Savannah, Georgia 4 Arlington, Texas 3 Boston, Massachusetts 3 Bowling Green, Kentucky 3 Caledonia, Michigan 3 Camp Hill, Pennsylvania 3 Detroit, Michigan 3 Doral, Florida 3 Fargo, North Dakota 3 Fremont, California 3 Frisco, Texas 3 Hollywood, Florida 3 Huntington Beach, California 3 Macon, Georgia 3 Margate, Florida 3 Norfolk, Virginia 3 North Little Rock, Arkansas 3 Oceanside, California 3 San Francisco, California 3 Spartanburg, South Carolina 3 The Bronx, New York 3 Tulsa, Oklahoma 3

Studies, page 3

  1. An Observational Retrospective Cohort Study Being Conducted in Women With Atopic Dermatitis (AD)

    The objective of this study is to describe and compare the incidence of adverse pregnancy outcomes (spontaneous abortion/miscarriage, stillbirth) and prevalence of adverse infant outcomes (major congenital malformations [MCMs], small for gestational age [SGA]) in women with AD who are treated with …

    Stage
    Not phased
    Ages
    18 to 49
    Site
    Regeneron Research Site, Boston, Massachusetts
    Run by
    Regeneron Pharmaceuticals

    See if you can join NCT03936335 on ClinicalTrials.gov

  2. Monitoring Pregnancy and Infant Outcomes Following Tralokinumab Exposure During Pregnancy in the US and Canada - PROTECT

    The goal of this observational study is to learn about exposure to tralokinumab during pregnancy, as well as atopic dermatitis (AD) during pregnancy. The main question the study aims to answer is whether pregnant people who have been exposed to tralokinumab during pregnancy experience any differenc…

    Stage
    Not phased
    Ages
    Any age
    Site
    University of California San Diego (UCSD), La Jolla, California
    Run by
    University of California, San Diego

    See if you can join NCT05938478 on ClinicalTrials.gov

  3. A Study to Assess Molecular Changes in Adult Participants With Moderate to Severe Hidradenitis Suppurativa or With Moderate to Severe Atopic Dermatitis Receiving Subcutaneous Injections of Lutikizumab

    Hidradenitis suppurativa (HS) and atopic dermatitis (AD) are chronic inflammatory skin diseases that lead to the development of skin lesions and symptoms such as pain and discomfort. The purpose of this study is to assess molecular changes in adult participants with moderate to severe HS or with mo…

    Stage
    Phase 2
    Ages
    18 to 75
    Site
    Physioseq, LLC /ID# 267266, Sacramento, California
    Locations
    2 in total
    Run by
    AbbVie

    See if you can join NCT06524635 on ClinicalTrials.gov

  4. Dupixent and Narrowband UVB for Atopic Dermatitis

    24 weeks open-label study with dupilumab and narrowband UVB phototherapy three times weekly for 12 weeks followed by 12 weeks of dupilumab monotherapy.

    Stage
    Phase 4
    Ages
    18 and older
    Site
    Eczema Treatment Center of New Jersey, East Windsor, New Jersey
    Run by
    Psoriasis Treatment Center of Central New Jersey

    See if you can join NCT05285839 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.